Copyright 2024
Medical Security Card Company, LLC
All Rights Reserved
WellRx will never sell your personal information. Period. By signing up I agree to WellRx's terms of use and privacy policy.
BICTEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE (bik TEG ra veer; em tri SIT uh bean; ten OF oh vir AL a FEN a mide) helps manage the symptoms of HIV infection. It works by limiting the spread of HIV in the body. It is a combination of three antiretroviral medications. This medication is not a cure for HIV or AIDS and it may still be possible to spread HIV to others while taking it. It does not prevent other sexually transmitted infections (STIs).
Bictegravir 50mg, Emtricitabine 200mg, Tenofovir Alafenamide 25mg, Oral tablet
Grapefruit juice
· Severity: Moderate
· Notes for Consumers: Side effects might get worse if you take this drug with grapefruit juice. Your prescriber may decide that taking these drugs together will benefit you. If you experience a worsening of side effects, contact your health care professional.
· Notes for Professionals: Caution is advised when administering tenofovir, PMPA, a P-glycoprotein (P-gp) substrate, concurrently with inhibitors of P-gp, such as grapefruit juice. Coadministration may result in increased absorption of tenofovir. Monitor for tenofovir-associated adverse reactions.
You need to log into the site to use this feature
You may find alternative ways to save with this medication. Talk to your pharmacist about the potential option(s) noted below.
Manufacturer Coupons and Offers Available
Number of Uses:
biktarvy
50-200-25 | Tablet | 30 tablets
You need to log into the site to use this feature
This feature requires registration. Sign up or log in to your free WellRx account to gain access to this and other tools to help make managing your medications and wellness easier.
Benefits Include:
This feature requires registration. Sign up or log in to your free WellRx account to gain access to this and other tools to help make managing your medications and wellness easier.
Benefits Include:
You will be redirected to your program in 5 seconds.
Our Terms and Conditions and Privacy Policy have recently been updated.
By declining you will be logged out of your account